Community level barriers for cervical cancer screening in marginalized population

Kranti Vora, Shahin Saiyed, Rajendra Joshi, Senthil Natesan


Background: In India, cervical cancer is the second common cause of cancer deaths among women of reproductive age, with 469 million Indian women at risk. High risk human papillomavirus genotypes mainly 16 and 18 account of cervical cancer. The burden of cervical cancer can be reduced by regular screening of human papillomavirus (HPV). There is no specific national program for cervical cancer screening. Eligible women have limited knowledge of screening and also limited access to preventive screenings.

Methods: The study was conducted in the slum areas of Ahmedabad city in Gujarat. 1088 women between 30-45 years of age were recruited in the study and 536 women consented to give cervical samples for DNA based HPV testing. We collected information regarding knowledge and practice for cervical cancer and HPV along with demographic data.

Results: Lack of knowledge and practices around cervical cancer and screening among community women was found. There is a lack of awareness about the importance of preventive healthcare and near absence of evidence-based practices. Sociodemographic characteristics are important predictors of participation in the screening program.

Conclusions: In the Indian context, HPV testing is a cost-effective option to prevent cervical cancer. The burden of cervical cancer is incredibly high. With increased ability to accurately detect, population level HPV testing would reduce the burden of cervical cancer and the ultimate cost per person would be minimal, due to the country’s large population. There is a need to develop policy to ensure participation of women in the HPV based cervical cancer screening programs.


Attitude, Cervical cancer, HPV, India, Knowledge, Urban slums

Full Text:



Human papillomavirus (HPV) and cervical cancer. Available at: Accessed on 10 February 2020.

Institute for health metrics and evaluation. The challenge ahead: progress and setbacks in breast and cervical cancer. Available at: http://www.healthdata. org/sites/default/files/files/policy_report/2011/TheChallengeAhead/IHME_ChallengeAhead_FullReport.pdf. Accessed on 10 February 2020.

India, human papillomavirus and related cancers, fact sheet 2018. Available at: statistics/reports/IND_FS.pdf. Accessed on 10 February 2020.

Krishnan S, Madsen E, Porterfield D, Varghese B, Poehlman J, Taylor O. Advancing cervical cancer prevention in India. Health, nutrition, and population global practice knowledge brief. Available at: Accessed on 10 February 2020.

Mark S, Nicolas W, Sholom W, Walter K, Julia CG, Philip EC. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103:368-83.

Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: Status & current concepts. Indian J Med Res. 2018; 148:687-96.

Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis. 2005;5:116.

Senapati R, Nayak B, Kar SK, Dwibedi B. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India. Bio Med Cent Infect Dis. 2017;17:30.

Early detection tests to prevent cervical cancer, Fact sheet 4. Health education series on human papillomavirus and cervical cancer. Available at: 270〈=en. Accessed on 10 February 2020.

National Institute of cancer prevention and research. operational guidelines for the prevention, screening and control of common non-communicable diseases: Hypertension, diabetes and common cancers (oral, breast, cervix). Available at: images/pdf/guidelines_for_population_level_screening_of_common_NCDs.pdf. Accessed on 10 February 2020.

Mishra GA, Pimple SA, Shastri SS. An overview of prevention and early detection of cervical cancers. Indian J Med Paediatr Oncol. 2011;32:125-32.

Hawkes D. Human papillomavirus testing as part of the renewed National cervical screening program. Aust J Gen Pract. 2018;47:412-4.

Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. World J Clin Oncol. 2015;6:281-90.

Pesola F, Sasieni P. Impact of screening on cervical cancer incidence in England: a time trend analysis. Brit Med J Op. 2019;9:e026292.

Nwankwo K, Aniebue U, Aguwa E, Anarado A, Agunwah E. Knowledge attitudes and practices of cervical cancer screening among urban and rural Nigerian women: A call for education and mass screening. Eur J Cancer Care. 2011;20:362-7.

Ebu NI, Mupepi SS, Siakwa MP, Sampselle CM. Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern Ghana. Int J Womens Health. 2014;7:31-9.

Population enumeration data (final population). Census of India 2011. Available at: Accessed on 10 February 2020.

Dhivya B, Balakrishnan P. Cervical cancer screening: Knowledge, attitude and practices in a primary health centre in rural India. J Evid Based Med Healthc. 2015;2:4530-9.

Nyblade L, Stockton M, Travasso S, Krishnan S. A qualitative exploration of cervical and breast cancer stigma in Karnataka, India. Bio Med Cent Women’s Health. 2017;17:58.

Montgomery MP, Dune T, Shetty PK, Shetty AK. Knowledge and acceptability of human papillomavirus vaccination and cervical cancer screening among women in Karnataka, India. J Cancer Educ. 2014;30:130-7.

Basu P, Sarkar S, Mukherjee S, Ghoshal M, Mittal S, Biswas S, et al. Women’s perceptions and social barriers determine compliance to cervical screening: Results from a population-based study in India. Cancer Detect Prev. 2006;30:369-74.

WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Available at: handle/10665/94830/9789241548694_eng.pdf;jsessionid=DCC6455F6EA923C320E77982027A04AA?sequence=1. Accessed on 10 February 2020.